发明名称 |
CONTROLLED RELEASE FORMULATIONS OF LORAZEPAM |
摘要 |
<p>Controlled release of lorazepam can provide enhanced dosing options including once daily dosing that provides 24 hour therapeutic effect under steady state conditions. The pharmaceutical composition can provide substantially zero order release and 90% release within 7 to 12 hours in a pharmaceutical dissolution test. The release can be achieved using polyethylene oxide as a matrix polymer.</p> |
申请公布号 |
CA2897313(A1) |
申请公布日期 |
2014.07.17 |
申请号 |
CA20142897313 |
申请日期 |
2014.01.09 |
申请人 |
EDGEMONT PHARMACEUTICALS LLC |
发明人 |
SALTEL, DOUGLAS A.;VACHON, MICHAEL |
分类号 |
A61K9/20;A61K31/5513 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|